Navigation Links
MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results
Date:3/13/2008

cond quarter of 2008, with results available in the second half of 2008 and if the results of this trial are positive, Cadence submitting a new drug application (NDA) for Omigard(TM) in the first half of 2009; our plans to add approximately six patients at 600 mg dose in the celgosivir Phase II viral kinetics study and having results from the study in the third quarter of 2008; Cutanea Life Sciences' plans to advance omiganan for the treatment of rosacea into Phase III clinical development in 2008, our estimate of the probable royalties payable to the holders of the convertible royalty participation units; our plans to advance MX-2401 into the clinic in late 2009; Spring Bank's plans to advance the SB 9000 program into the clinic in 2009; the Company continuing to advance its highest priority programs while operating within an annual burn rate of $9 million to $10 million; and the Company's financial resources being sufficient to fund operations into the fourth quarter of 2008.

With respect to the forward-looking statements contained in this news release, we have made numerous assumptions regarding, among other things: Cadence's ability to enroll sufficient patients to complete the Omigard(TM) Phase III trial; the adequacy of the Omigard(TM) Phase III trial design to generate data that are deemed sufficient by regulatory authorities to support potential regulatory filings, including an NDA, for Omigard(TM); our ability to enroll approximately six patients at the 600 mg dose in the celgosivir Phase II viral kinetics study and having results from the study in the third quarter of 2008; Cutanea's ability to manage, fund and advance omiganan for dermatological applications into Phase III, the adequacy of Cutanea's Phase II results for regulatory authorities to support advancing to Phase III; Spring Bank's ability to manage, fund and advance SB 9000 into clinical development; our ability to manage licensing opportunities; our ability to initiate, fund and complete
'/>"/>

SOURCE MIGENIX Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. MIGENIX Third Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
2. MIGENIX releases CEO message #22
3. MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study
4. MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results
5. MIGENIX Second Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
6. MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
7. MIGENIX Reports First Quarter Fiscal Year 2008 Financial Results
8. MIGENIX to Present Positive Celgosivir Viral Resistance Data at International HCV Meeting
9. MIGENIX First Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
10. Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results
11. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...test pilots push planes to explore their limits, r...and Technology (NIST) are probing the newest micro...curacy at the nanoscale. Better nanoscale measurem...ing production in the semiconductor and nanomanufa...logy uses helium ions to generate the signal used ...
(Date:9/5/2008)...e Food & Drug Administration (FDA) issued in July ...port acknowledged that nanoscale materials potenti... by the agency and that those materials present ch...elevant to product safety and effectiveness may ch...icipating the potential for rapid commercializatio...
(Date:9/5/2008)...us, gold is only valuable if we possess it in larg...le isn,t the case for those interested in exploiti...ariety of chemical reactions, including the oxidat...s carbon dioxide at room temperatures. That proces...e effectiveness of catalytic converters that clean...
(Date:9/5/2008)...ept. 5 /- Gen-Probe Incorpo...mpany will present at the Morgan,Stanley Global He...r 9,2008 at approximately 2:45 p.m. Eastern Time....and may be accessed through a link on the investor...n-probe.com . The webcast,will be available for 30...
Breaking Biology Technology:NIST studies how new helium ion microscope measures up 2Nanotechnology and the FDA: size matters 2NIST and partners identify tiny gold clusters as top-notch catalysts 2Gen-Probe to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference 2
...local and national radio advertising for small bus... and its Audio Ads network includes hundreds of ra...t mean for marketers who need to create a radio ad.... , ,"Over the last year, we,ve been partnering wi...cross the U.S. so that our advertisers have many o...
...Mexico-based biotechnology company, has selected t...o manufacture its DNA-based, pre-flu vaccine. , ... Waisman Center , the biomanufacturing facility is... pharmaceutical products for Phase I and II human ...ials underway before the end of next year,s flu se...
...w strategic plan featuring enhancements to 25 rout...s announced the launch of nonstop Midwest Connect ..., the airport that serves Research Triangle Park ... fending off a hostile takeover bid by AirTran Hol...equested destination of business travelers because...
...ered the spawning ground for the next wave of high...growth in the national angel market, a diversified...ional investors. , ,In its 2006 Angel Market Anal...niversity of New Hampshire reports that angel inv...al investments of $25.6 billion. , ,A report on 2...
Other Biology Technology:See how they run: Radio ads and Google 2See how they run: Radio ads and Google 3See how they run: Radio ads and Google 4National angel investment grew 11 percent in `06 2National angel investment grew 11 percent in `06 3
(Date:9/5/2008)...work as recently illustrated by the flightless and...a. This cricket relative is found in New Zealand a...ales weighing in at 20 g, averaging twice the size...aland, published in the September issue of The Am...he University of Toronto at Mississauga discovered...
(Date:9/5/2008)... challenge of surviving in a changing climate. Res...Claude Bernard Lyon have shown how a sheep populat...and responds to two consequences of climate change...ty of winter storms. Dr. Thomas Ezard, lead author...food is plentiful, lambs contribute almost twice a...
(Date:9/5/2008)...nies of a critically endangered vulture, whose num...ns to a few thousand, are too small to protect the... analysis shows. , Adding wild birds to the capt...ucial, but political and logistical barriers are h.... , The study was published online August 15 in ...
(Date:9/5/2008)...e Gustav is shown via a sequence of satellite imag... Spectrometer (MERIS) instrument on 25 August, 28 ... to left). , Gustav formed on 25 August 2008 som...above far right image), when a tropical wave devel...visible), causing the U.S. National Hurricane Cent...
Breaking Biology News(10 mins):Lightweight and long-legged males go the distance for sex 2Recovery efforts not enough for critically endangered Asian vulture 2Recovery efforts not enough for critically endangered Asian vulture 3Hurricane Gustav 2Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements 23428 1Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements 23428 2Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements 23428 3Yale Keck Microarray Center Becomes a GeneGo Center of Excellence 6405 1Yale Keck Microarray Center Becomes a GeneGo Center of Excellence 6405 2Pharmasset Announces Initiation of Combination Study of Clevudine and Viread 28R 29 for HBV by French National Agency for Research on AIDS and Viral H 2591 1Pharmasset Announces Initiation of Combination Study of Clevudine and Viread 28R 29 for HBV by French National Agency for Research on AIDS and Viral H 2591 2Pharmasset Announces Initiation of Combination Study of Clevudine and Viread 28R 29 for HBV by French National Agency for Research on AIDS and Viral H 2591 3Pharmasset Announces Initiation of Combination Study of Clevudine and Viread 28R 29 for HBV by French National Agency for Research on AIDS and Viral H 2591 4Embryo biopsy does not affect early growth and risk of congenital malformations in PGD PGS babies 3931 1Embryo biopsy does not affect early growth and risk of congenital malformations in PGD PGS babies 3931 2Embryo biopsy does not affect early growth and risk of congenital malformations in PGD PGS babies 3931 3
...er blood vessels within the tissue of previously e...ignificant improvement in heart function. The stu... , With heart disorders affecting individuals glo...es, there has been a need to develop new treatment...ield of tissue engineering is to produce blood ves...
...ts will be the first in the area to insert a new t...hink of it as a contact lens inside your eye," sai...lantable collamer lens, or ICL, today for the firs... The ICL can replace or reduce the need for glasse...ficial lens in front of the eye,s natural lens, ra...
...ed breakdown of myelin, the fatty insulation coati...y with the presence of a key genetic risk factor f...in the January edition of the peer-reviewed journa...ing body of evidence that myelin breakdown is a ke...ter in life. , In addition, the study demonstrate...
...report describing the occurrence of pesticides in ...ort concludes that pesticides are typically presen... agricultural areas of the Nation, but are less co...hat pesticides are seldom at concentrations likely...cularly those draining urban and agricultural area...
Other Biology News:New 'implanted contacts' designed to fix nearsightedness 2Imaging study links key genetic risk for Alzheimer's disease to myelin breakdown 2Pesticides in the nation's streams and ground water 2Pesticides in the nation's streams and ground water 3Pesticides in the nation's streams and ground water 4
BD FACSAria Cell Sorting System from BD Biosciences - Immunocytometry Systems
Kit Components: Anti-PARP LumiGLO Chemiluminescent Substrate Immunoblot Blocking Reagent Pyronin Y Reagent Goat Anti-Rabbit IgG, HRP conjugate Double-It Reagent Film Exposure Folders Autor
...nt/server version of Freezerworks Unlimited includ...kflow in high-volume labs and facilitates the shar...d to share sample information. Network Clien...PC 601); 13 in monitor with 256 colors; OS 8.6 & O...
Polypropylene test tube racks, used in Thermo Forma's line of Test Tube Rack holders
Biology Products: